Information Provided By: 
Fly News Breaks for April 8, 2019
MNK, ENDP
Apr 8, 2019 | 06:09 EDT
Mizuho analyst Irin Koffler believes a potential Purdue Pharma bankruptcy could benefit opioid defendants in that it could introduce "meaningful delays, lessen the body of evidence against other drug manufacturers, and potentially force the plaintiffs to rethink their original strategy and negotiating position (leading to lower settlements)." The risks are to the upside for Neutral-rated Endo (ENDP) and Mallinckrodt (MNK) as the opioid litigation progresses, Koffler tells investors in a research note.
News For ENDP;MNK From the Last 2 Days
There are no results for your query ENDP;MNK
